About Logos
Logos is a private equity firm founded in 2007. It is primarily based in San Francisco, United States. In the last 12 months, it has participated in 9 funding rounds.
A lot of funds co-invest with Logos, with names like Janus Henderson Investors sharing a substantial percentage of its portfolio.
Logos has a team of 8 people, including 2 partners.
Key Metrics
Logos' Portfolio
They have invested in a total of 98 companies. Their most recent investment was in Expedition Therapeutics (Series B round) on Aug 05, 2026. Here is the most recent investment by Logos:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Aug 05, 2026 | Series B | 6780 | ||
May 18, 2026 | Post IPO | 2456 | ||
Apr 14, 2026 | Series C | 5219 | ||
Mar 11, 2026 | Post IPO | 8005 |
Here is the portfolio snapshot of Logos:
Investments by Year
The maximum number of investments were made in 2021
Team profile of Logos
Logos has a team of 8 members including 2 Partners and 1 Principal located in United States. Logos' team does not sit on the board of any company as of now.Here is a list of all team members in Logos:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York | - | ||
Partner | San Francisco | - | ||
Principal | - | - | ||
Analyst | New York City | - | ||
Analyst | San Francisco | - | ||
Analyst | United States | - |
Co-investors of Logos
Over the past 19 years, 245 investors have co-invested in Logos's portfolio companies.
- Top Co-investors of Logos: 245 investors entered a company along with Logos. These include investors like Janus Henderson Investors (41 companies).
Logos News
•
Adcendo ApS Completes $75 Million Series C FinancingCNW•Apr 14, 2026•Jeito, Bpifrance, Danmarks Eksport og Investeringsfond, Adcendo and 12 others
•
Pinnacle raises an $89M series B for its oral peptide programsBioWorld•Mar 26, 2026•Pinnacle Medicines, LAV, Foresite Capital, Logos and 4 others
•
Secretive startup Mirador raises $250M, plans to become immunology powerhouseEndpoints•Jan 11, 2026•Mirador, Fidelity Investments, Blue Owl, Adage Capital Management and 13 others
•
Diagonal Therapeutics Announces $125 Million Series B FinancingBenzinga•Jan 08, 2026•Diagonal Therapeutics, Sanofi Ventures, Janus Henderson Investors, RV Invest and 13 others
•
Pathway to Cures Invests in SeraGene TherapeuticsBusiness Wire•Nov 19, 2025•SeraGene, Pathwaytocures, Blue Owl, Adage Capital Management and 5 others
•
Beacon Biosignals Raises $86M to Build and Mine Brain Data TroveEndpoints•Nov 12, 2025•Beacon Biosignals, Innoviva, Takeda, Google Ventures and 7 others
•
Expedition Therapeutics Raises $165 Million in Series A Funding for COPD InhibitorBusiness Wire•Oct 09, 2025•Expedition Therapeutics, Novo Holdings, Sofinnova Investments, Adage Capital Management and 8 others
•
Verdiva Bio Raises Over $410M in Series A FinancingFinSMEs•Jan 13, 2025•Verdiva Bio, Orbimed, Logos, Lilly
•
Verdiva Bio joins weight loss race with $411M Series APitchBook•Jan 10, 2025•Verdiva Bio, Forbion, General Atlantic, Orbimed and 6 others
•
Verdiva Jumps Into Hot Obesity Market With $410M Debut, Eyes Next-Gen TherapiesBioSpace•Jan 09, 2025•Verdiva Bio, Forbion, General Atlantic, RA Capital Management and 4 others
